Leukocyte-endothelial cell interactions in nitric oxide synthase- deficient mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 6 45-6, 1999, Pages

  Lefer, David J ^a   Jones, Steven P ^a   Girod, Wesley G ^a   Baines, Amarpreet ^c   Grisham, Matthew B ^a   Cockrell, Adam S ^a   Huang, Paul L ^b   Scalia, Rosario ^c  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Endothelium; Gene targeted mice; Microcirculation; Neutrophil; P selectin

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PADGEM PROTEIN;

ANIMAL CELL; ARTICLE; BLOOD FLOW VELOCITY; CELL INTERACTION; CELL MOTILITY; ENZYME ACTIVITY; LEUKOCYTE ADHERENCE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; VASCULAR ENDOTHELIUM;

EID: 0033000347     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.6.h1943     Document Type: Article

References (49)

1. Carey, C., M. R. Siegfried, X.-L. Ma, A. S. Weyrich, and A. M. Lefer. Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion. Circ. Shock 38: 209-216, 1992.
2. Davenpeck, K. L., T. W. Gauthier, and A. M. Lefer. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression in the rat microcirculation. Gastroenterology 107: 1050-1058, 1994.
3. Davis, M. J. Determination of volumetric flow in capillary tubes using an optical Doppler velocimeter. Microvasc. Res. 34: 223-230, 1987.
4. De Caterina, R., P. Libby, H.-B. Peng, V. J. Thannickol, T. B. Rajavashisth, M. A. Gimbrone, W. S. Shin, and J. K. Liao. Nitric oxide decreases cytokine-induced endothelial activation: NO selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96: 60-68, 1995.
5. Dubey, R. K., and H. W. Overbeck. Culture of rat mesenteric arteriolar smooth muscle cells: effects of platelet-derived growth factor, angiotensin, and nitric oxide on growth. Cell Tissue Res. 275: 133-141, 1994.
6. Faraci, F. M., C. D. Sigmund, E. G. Shesely, N. Maeda, and D. D. Heistad. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am. J. Physiol. 274 (Heart Circ. Physiol. 43): H564-H570, 1998.
7. Ferriero, D. M., D. M. Holtzman, S. M. Black, and R. A. Sheldon. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol. Dis. 3: 64-71, 1996.
8. Fox-Robichaud, A., D. Payne, S. U. Hasan, L. Otrovsky, T. Fairhead, P. Reinhardt, and P. Kubes. Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J. Clin. Invest. 101: 2497-2505, 1998.
9. Gaboury, J., R. C. Woodman, D. N. Granger, P. Reinhardt, and P. Kubes. Nitric oxide prevents leukocyte adherence: role of Superoxide. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H862-H867, 1993.
10. Garg, U. C., and A. Hassid. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1774-1777, 1989.
11. Gauthier, T. W., K. L. Davenpeck, and A. M. Lefer. Nitric oxide attenuates leukocyte-endothelial cell interaction via P-selectin in splanchnic ischemia-reperfusion. Am. J. Physiol. 267 (Gastrointest. Liver Physiol. 30): G562-G568, 1994.
12. Gilkeson, G. S., J. S. Mudgett, M. F. Seldin, P. Ruiz, A. A. Alexander, M. A. Misukonis, D. S. Pietsky, and J. B. Weinberg. Clinical and serological manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. J. Exp. Med. 186: 365-373, 1997.
13. Granger, D. N., J. N. Benoit, M. Suzuki, and M. B. Grisham. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am. J. Physiol. 257 (Gastrointest. Liver Physiol. 20): G683-G688, 1989.
14. G-nitroarginine binding after transient focal ischemia and NMDA-induced excitotoxicity in type I and type III nitric oxide synthase null mice. J. Cereb. Blood Flow Metab. 17: 515-526, 1997.
15. Hickey, M. J., K. A. Sharkey, E. G. Sihota, P. H. Reinhardt, J. D. Macmicking, C. Nathan, and P. Kubes. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 11: 955-964, 1997.
16. Huang, Z., P. L. Huang, J. Ma, W. Meng, C. Ayata, M. C. Fishman, and M. A. Moskowitz. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J. Cereb. Blood Flow Metab. 16: 981-987, 1996.
17. Huang, P. L., Z. Huang, H. Mahimo, K. D. Bloch, M. A. Moscowitz, J. A. Bevan, and M. C. Fishman. Hypertension in mice lacking the gene for endothelial cell nitric oxide synthase. Nature 377: 239-242, 1995.
18. Huang, P. L., T. M. Dawson, D. Bredt, and S. H. Snyder. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75: 1273-1286, 1993.
19. Iadecola, C., F. Zhang, R. Casey, M. Nagayama, and M. E. Ross. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17: 9157-9164, 1997.
20. Kelm, M., and J. Schrader. Control of coronary vascular tone by nitric oxide. Circ. Res. 66: 1561-1575, 1990.
21. Klimaschewski, L., W. Kummer, B. Mayer, J. Y. Couraud, U. Preissler, B. Philippin, and C. Heym. Nitric oxide synthase in cardiac nerve fibers and neurons of rat and guinea pig heart. Circ. Res. 71: 1533-1537, 1992.
22. Koglin, J., T. Glysing-Jensen, J. S. Mudgett, and M. E. Russell. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation 97: 2059-2065, 1998.
23. Kubes, P., M. Suzuki, and D. N. Granger. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88: 4651-4655, 1991.
24. Kubes, P., and D. N. Granger. Nitric oxide modulates microvascular permeability Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H611-H615, 1992.
25. Kurose, I., R. Wolf, M. B. Grisham, and D. N. Granger. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ. Res. 74: 376-382, 1993.
26. Kurose, I., R. Wolf, M. B. Grisham, and D. N. Granger. Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2224-H2231, 1995.
27. Laubach, V. E., E. G. Shesely, O. Smithies, and P. A. Sherman. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA 92: 10688-10692, 1995.
28. Lefer, D. J., K. Nakanishi, W. E. Johnston, and J. Vinten-Johansen. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 88: 2337-2350, 1993.
29. Lefer, D. J., R. Scalia, B. Campbell, T. Nossuli, R. Hayward, M. Salamon, J. Grayson, and A. M. Lefer. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J. Clin. Invest. 99: 684-691, 1997.
30. Loscalzo, J., and G. Welch. Nitric oxide and its role in the cardiovascular system. Prog. Cardiovasc. Dis. 38: 87-104, 1995.
31. MacMicking, J. D., C. Nathan, G. Horn, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q. W. Xie, K. Sokol, N. Hutchinson, H. Chen, and J. S. Mudgett. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650, 1995.
32. McCafferty, D. M., J. S. Mudgett, M. G. Swain, and P. Kubes. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 112: 1022-1027, 1997.
33. Meng, W., C. Ayata, C. Waeber, P. L. Huang, and M. A. Moskowitz. Neuronal NOS-cGMP-dependent ACh-induced relaxation in pial arterioles of endothelial NOS knockout mice. Am. J. Physiol. 274 (Heart Circ. Physiol. 43): H411-H415, 1998.
34. Michel, T., and O. Feron. Perspective series: nitric oxide synthases. J. Clin. Invest. 100: 2146-2152, 1997.
35. Moncada, S., R. M. J. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
36. Moroi, M., L. Zhang, T. Yasuda, R. Virmani, H. K. Gold, M. C. Fishman, and P. L. Huang. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J. Clin. Invest. 101: 1225-1232, 1998.
37. Murohara, T., T. Asahara, M. Silver, C. Bauters, H. Masuda, C. Kalka, M. Kearney, D. Chen, J. F. Symes, M. C. Fishman, P. L. Huang, and J. M. Isner. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101: 2567-2578, 1998.
38. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064, 1992.
39. Niu, X., C. W. Smith, and P. Kubes. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ. Res. 74: 1133-1140, 1994.
40. Pabla, R., A. J. Buda, D. M. Flynn, S. A. Blesse, A. M. Shin, M. J. Curtis, and D. J. Lefer. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ. Res. 78: 65-72, 1996.
41. Radomski, M. W., R. M. J. Palmer, and S. Moncada. The anti-aggregating properties of vascular endothelium: interaction between prostacyclin and nitric oxide. Br. J. Pharmacol. 92: 639-646, 1987.
42. Shesely, E. G., N. Maeda, H. S. Kim, K. M. Desai, J. H. Krege, V. E. Laubach, P. A. Sherman, W. C. Sessa, and O. Smithies. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 93: 13176-13181, 1996.
43. Shin, W. S., Y. H. Hong, H. B. Peng, R. De Caterinia, P. Libby, and J. K. Liao. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-γ. The role of constitutive NF-κB activity. J. Biol. Chem. 271: 11317-11324, 1996.
44. Stamler, J. S., and J. Loscalzo. The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders. J. Am. Coll. Cardiol. 18: 1529-1536, 1991.
45. Steudel, W., F. Ichinose, P. L. Huang, W. E. Hurford, R. C. Jones, J. A. Bevan, M. C. Fishman, and W. M. Zapol. Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS) gene. Circ. Res. 81: 34-41, 1997.
46. Toda, N., and T. Okamura. Nitroxidergic nerve: regulation of vascular tone and blood flow in the brain. J. Hypertens. 14: 423-434. 1996.
47. Toda, N., and T. Okamura. Regulation by nitroxidergic nerve of arterial tone. News Physiol. Sci. 7: 148-152, 1992.
48. Weyrich, A. S., X.-L. Ma, and A. M. Lefer. The role of L-arginine in ameliorating reperfusion injury after myocardia ischemia in the cat. Circulation 86: 279-288, 1993.
49. Wink, D., A., I. Hanbauer, M. C. Krishna, W. DeGraff, J. Gamson, and J. B. Mitchell. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. USA 90: 9813-9817, 1993.